VIVUS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-03-17: Reporting owner Sanford Svai S; Form 3/A; Security Employee Stock Option (right to buy); Transaction Holding.
- 2014-03-17: Reporting owner Sanford Svai S; Form 3/A; Security Employee Stock Option (right to buy); Transaction Holding.
- 2014-01-28: Reporting owner Sanford Svai S; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-01-28: Reporting owner Slebir John L; Form 4; Security Employee Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-03-17 holding as of filing | Sanford Svai S Officer (Inter. Chief Financial Officer) | 3/A | Employee Stock Option (right to buy) Derivative · Direct | Holding | $12.39 exercise price | 2014-03-17 | ||
| 2014-03-17 holding as of filing | Sanford Svai S Officer (Inter. Chief Financial Officer) | 3/A | Employee Stock Option (right to buy) Derivative · Direct | Holding | $22.63 exercise price | 2014-03-17 | ||
| 2014-01-28 | Sanford Svai S Officer (Interim CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,300 38,300 owned after | $7.75 exercise price | 2014-01-30 | |
| 2014-01-28 | Slebir John L Officer (SVP & General Counsel) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 51,000 owned after | $7.75 exercise price | 2014-01-30 | |
| 2014-01-28 | MARSH GUY P Officer (VP, Operations and General Mgr) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,500 25,500 owned after | $7.75 exercise price | 2014-01-30 | |
| 2014-01-28 | Day Wesley Officer (VP, Clinical Development) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,300 38,300 owned after | $7.75 exercise price | 2014-01-30 |